Validity of self-reported varicella disease history in pregnant women attending prenatal clinics

Public Health Reports

Volumn 122, Issue 4, 2007, Pages 499-506

  Watson, Barbara ^a   Civen, Rachel ^b   Reynolds, Meredith ^c   Heath, Karl ^a   Perella, Dana ^a   Carbajal, Tina ^b   Mascola, Laurene ^b   Jumaan, Aisha ^c   Zimmerman, Laura ^c   James, Abike ^d   Quashi, Carlene ^e   Schmid, Scott ^c  

^a PHILADELPHIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^b Los Angeles County Department of Public Health   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY;

ADULT; ANAMNESIS; ANTIBODY SPECIFICITY; ARTICLE; BLOOD SAMPLING; CHICKENPOX; CONFIDENCE INTERVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNITY; OUTPATIENT DEPARTMENT; PREDICTOR VARIABLE; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT; SEROLOGY; SEROPREVALENCE; VACCINATION; VALIDITY; VARICELLA ZOSTER VIRUS; WHOLE CELL; ADOLESCENT; BLOOD; IMMUNOLOGY; MIDDLE AGED; PREGNANCY; REPRODUCIBILITY; VALIDATION STUDY;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CHICKENPOX; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MIDDLE AGED; PREGNANCY; PRENATAL CARE; REPRODUCIBILITY OF RESULTS; SEROLOGIC TESTS;

EID: 34547700799     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/003335490712200411     Document Type: Article

References (25)

1. Centers for Disease Control and Prevention (US). Prevention of varicella - provisional updated ACIP recommendations for varicella vaccine use [cited 2007 Mar 9]. Available from: URL: http://www.cdc.gov/nip/vaccine/varicella/ varicella-acip-recs-prov-june-2006.pdf
2. Guris D, Jumaan AO, Mascola L, Watson B, Zhang JX, Chaves SS, et al. Changing varicella epidemiology in active surveillance sites - United States, 1995-2005. J Infect Dis. In press 2007.
3. Silverman NS, Ewing SH, Todi N, Montgomery OC. Maternal varicella history as a predictor of varicella immune status. J Perinatol 1996;16:35-38 (Pubitemid 126432784)
4. Rothman KJ, Greenland S. Modern epidemiology, 2nd edition. Philadelpha: Lippincott, Williams, and Wilkins; 1998. p. 509-510
5. Hollier LM, Grissom H. Human herpes viruses in pregnancy: cytomegalovirus, Epstein-Barr virus, and varicella zoster virus. Clin Perinatol 2005;32:671-696 (Pubitemid 41111997)
6. Tan MP, Koren G. Chickenpox in pregnancy: revisited. Reprod Toxicol 2006;21:410-420
7. Sauerbrei A, Wutzler P. Neonatal varicella. J Perinatol 2001;21:545-549 (Pubitemid 34055855)
8. Enders G, Miller E. Varicella and herpes-zoster in pregnancy and the newborn. In: Arvin AM, Gershon AA, editors. Varicella-zoster virus. Cambridge (England): Cambridge University Press; 2000. p. 317-347
9. Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 1994;343:1548-1551 (Pubitemid 24180055)
10. Harger JH, Ernest JM, Thurnau GR, Moawad A, Thom E, Landon MB, et al.; National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Frequency of congenital varicella syndrome in a prospective cohort of 347 pregnant women. Obstet Gynecol 2002;100:260-265
11. Harger JH, Ernest JM, Thurnau GR, Moawad A, Momirova V, Landon MB, et al.; National Institute of Child Health and Human Development, Network of Maternal-Fetal Medicine Units. Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women. J Infect Dis 2002;185:422-427
12. Gershon A, Takahashi M, Seward J. Varicella vaccine. In: Plotkin SA, Orenstein WA, editors. Vaccines, 4th edition. Philadelphia: Elsevier, Inc.; 2004. p. 783-824.
13. A new product (VariZIG) for postexposure prophylaxis of varicella available under an investigational new drug application expanded access protocol. MMWR Morb Mortal Wkly Rep 2006;55(8):209-210
14. Behrman A, Schmid S, Crivaro A, Watson B. A cluster of primary varicella cases among healthcare workers with false-positive varicella zoster virus titers. Infect Control Hosp Epidemiol 2003;24:202-206 (Pubitemid 36383457)
15. VARIVAX package inserts. Merck & Co., Inc., West Point (PA). July 1996.
16. White CJ, Kuter BJ, Hildebrand CS, Isganitis KL, Matthews H, Miller WJ, et al. Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989. Pediatrics 1991;87:604-610
17. SAS Institute Inc. SAS: Version 9.1 for Windows. Cary (NC): SAS Institute Inc.; 2006.
18. Seward JF, Watson BM, Peterson CL, Mascola L, Pelosi JW, Zhang JX, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 2002;287:606-611
19. Goldberg JM, Ziel HK, Burchette R. Evaluation of varicella immune status in an obstetric population in relation to place of birth. Am J Perinatol 2002;19:387-394 (Pubitemid 35231565)
20. Plourd DM, Austin K. Correlation of a reported history of chickenpox with seropositive immunity in pregnant women. J Reprod Med 2005;50:779-783 (Pubitemid 41502436)
21. Wise RP, Salive ME, Braun MM, Mootrey GT, Seward JF, Rider LG, et al. Postlicensure safety surveillance for varicella vaccine. JAMA 2000;284:1271-1279
22. Kilgore PE, Kruszon-Moran D, Seward JF, Jumaan A, Van Loon FP, Forghani B, et al. Varicella in Americans from NHANES III: implications for control through routine immunization. J Med Virol 2003;70(Suppl 1):S111-8.
23. Barnett ED, Christiansen D, Figueira M. Seroprevalence of measles, rubella, and varicella in refugees. Clin Infect Dis 2002;35:403-408
24. Kjersem H, Jepsen S. Varicella among immigrants from the tropics, a health problem. Scand J Soc Med 1990;18:171-174 (Pubitemid 20266865)
25. Maretic Z, Cooray MP. Comparisons between chickenpox in a tropical and a European country. J Trop Med Hyg 1963;66:311-315